Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
In the news release, Alteon Signs Agreements for Sale of Approximately $1.4 Million in Common Stock PIPE Transaction, issued earlier today by Alteon, Inc. over PR Newswire, we are advised by the...
Alteon Updates Investors on Alagebrium Development Status - Alagebrium Preclinical Toxicity Tests Progressing; Company Intends to Perform SPECTRA Clinical Trial Interim Analysis - PARSIPPANY...
Alteon Announces Year-End and Fourth Quarter Results PARSIPPANY, N.J., March 15 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX: ALT) announced today a net loss of $13,958,646 for the year ended...
Alteon Initiates Phase 2 Trial of Alagebrium in Erectile Dysfunction - 'EMERALD' Trial to Test the Efficacy of Alagebrium in Diabetic Men Who Achieve Limited Benefit from Current Therapies...
Alteon to Present at the Credit Suisse First Boston Healthcare Conference Friday, November 19, 2004 PARSIPPANY, N.J., Nov. 11 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX: ALT) announced today...
Alteon Issued Key Composition-of-Matter Patent Covering Additional A.G.E. Crosslink Breakers to Treat Diseases of Aging and Diabetes PARSIPPANY, N.J., Sept. 20 /PRNewswire-FirstCall/ -- Alteon...
Alteon to Change Principal Accountants PARSIPPANY, N.J., Aug. 13 /PRNewswire-FirstCall/ -- Alteon Inc. today announced that KPMG LLP ("KPMG") has informed the company that it has resigned as...
Alteon Announces Resignation of Senior Vice President Robert C. deGroof, Ph.D. PARSIPPANY, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Alteon Inc. today announced the resignation of Robert C...
Alteon's Investigational Drugs Demonstrate Ability to Reduce Atherosclerosis - Preclinical Study in 'Diabetes' Also Identifies Important Role of Sugar in Atherosclerosis - PARSIPPANY, N.J., June...
Detailed Data on Alteon's Hypertension/Heart Failure Drug Candidate Alagebrium to Be Presented at The American Society of Hypertension Meeting PARSIPPANY, N.J., April 27 /PRNewswire-FirstCall/...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.005 | 100 | 0.005 | 0.01 | 0.005 | 232 | 0.00931034 | CS |
| 4 | 0.005 | 100 | 0.005 | 0.01 | 0.005 | 2841 | 0.00552796 | CS |
| 12 | 0.005 | 100 | 0.005 | 0.01 | 0.005 | 10282 | 0.00602769 | CS |
| 26 | 0 | 0 | 0.01 | 0.01 | 0.005 | 6561 | 0.00714767 | CS |
| 52 | -0.01 | -50 | 0.02 | 0.02 | 0.005 | 14946 | 0.0069007 | CS |
| 156 | -0.01 | -50 | 0.02 | 0.03 | 0.005 | 9248 | 0.01335971 | CS |
| 260 | 0.005 | 100 | 0.005 | 0.045 | 0.005 | 24362 | 0.02043385 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
